A new model to predict remission status in AML patients based on day 14 bone marrow biopsy

Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

Bruce D. Cheson, John M. Bennett, Thomas Büchner et al. · Journal of Clinical Oncology · 2003 · 2.7K citations

Medicine, Hematology, Oncology +17

Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial

Wolfgang Kern, Torsten Haferlach, Claudia Schoch et al. · Blood · 2002 · 284 citations · Full text

Medicine, Hematology, Oncology +10

Adult patients with acute myeloid leukemia who achieve complete remission after 1 or 2 cycles of induction have a similar prognosis

Jacob M. Rowe, Haesook T. Kim, Peter A. Cassileth et al. · Cancer · 2010 · 109 citations · Full text

Medicine, Hematology, Oncology +12

Day 14 bone marrow biopsy in predicting complete remission and survival in acute myeloid leukemia

Kebede Hussein, Balkrishna Jahagirdar, Pankaj Gupta et al. · American Journal of Hematology · 2008 · 53 citations · Full text

Medicine, Hematology, Oncology +14

Bone marrow aspirate on the 14th day of induction treatment as a prognostic tool in de novo adult acute myeloid leukemia.

Vincenzo Liso, Francesco Albano, Donatella Pastore et al. · PubMed · 2000 · 51 citations

Medicine, Hematology, Oncology +15